Virax Biolabs Group Limited Ordinary Shares (VRAX)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
1,908,800
EV to revenue ratio (TTM)
107.34
EV to ebitda
0.423
Financial Performance
Revenue (TTM)
12,420
Gross profit (TTM)
7,690
EBITDA
-6,048,149
Profitability
Operating margin (TTM)
-35,265.00%
Profit margin
0.00%
Return on assets (TTM)
-54.20%
Return on equity (TTM)
-78.60%
Per Share Metrics
Revenue per share (TTM)
0.03
EPS
-12.64
Diluted EPS (TTM)
-12.64
Book value
13.08
Dividend per share
Dividend yield
Valuation Multiples
P/E ratio
Trailing P/E
Forward P/E
PEG ratio
Price to sales ratio (TTM)
153.65
Price to book ratio (TTM)
0.263
Growth
Quarterly earnings growth (YoY)
685.00%
Quarterly revenue growth (YoY)
0.00%
Analyst Sentiment
Strong buy
Buy
Hold
Sell
Strong sell
Risk & Volatility
Beta
1.355